science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.1106673 on June 18, 2007

Published online before print June 18, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1106673v1
82/3/700    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soares-Schanoski, A.
Right arrow Articles by López-Collazo, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soares-Schanoski, A.
Right arrow Articles by López-Collazo, E.
(Journal of Leukocyte Biology. 2007;82:700-709.)
© 2007 by Society for Leukocyte Biology

6-Methylprednisolone down-regulates IRAK-M in human and murine osteoclasts and boosts bone-resorbing activity: a putative mechanism for corticoid-induced osteoporosis

Alessandra Soares-Schanoski*,1, Vanesa Gómez-Piña*,1, Carlos del Fresno*,1, Alexandro Rodríguez-Rojas*, Felipe García{dagger}, Alberto Glaría{ddagger}, Miriam Sánchez*, María Teresa Vallejo-Cremades*, Rosa Baos*, Pablo Fuentes-Prior§, Francisco Arnalich|| and Eduardo López-Collazo*,2

* Research Unit, ‘La Paz’ Hospital, and
|| Department of Medicine, ‘La Paz’ Hospital Medical School, Universidad Autónoma de Madrid, Madrid, Spain;
{dagger} Discovery Unit, EMPIREO S.L., Madrid, Spain;
{ddagger} Instituto Madrileño de Oncología, Madrid, Spain; and
§ Cardiovascular Research Center, ICCC-CSIC, Sant Antoni Ma. Claret 167, Barcelona, Spain

2 Correspondence: Research Unit, ‘La Paz’ Hospital, Madrid 28046, Spain. E-mail: elopezc.hulp{at}salud.madrid.org

Osteoclasts are large, multinucleated cells, which originate from the fusion of macrophages. They play a central role in bone development and remodeling via the resorption of bone and are thus important mediators of bone loss, which leads to osteoporosis. IL-1R-associated kinase (IRAK)-M is a pseudokinase, which acts as a negative modulator of innate immune responses mediated by TLRs and IL-1R. Recently, it has been reported that IRAK-M also participates in the control of macrophage differentiation into osteoclasts. In addition, it was shown that IRAK-M knockout mice develop a strong osteoporosis phenotype, suggesting that down-regulation of this molecule activates osteoclast-mediated bone resorption. We studied the effect of the osteoporosis-inducing glucocorticoid, 6-methylprednisolone (6-MP), on IRAK-M expression in osteoclasts. Our results showed that osteoclasts, derived from THP-1 and RAW cells as well as human blood monocytes, differentiated into osteoclasts, express high levels of IRAK-M at mRNA and protein levels. In addition, 6-MP down-regulates IRAK-M expression, which correlates with an increased activation of bone resorption. These findings suggest a mechanism of corticosteroid-induced osteoporosis and open new avenues for treating this endemic disease of Western societies.

Key Words: glucocorticoids • TLR • IL-1R




This article has been cited by other articles:


Home page
 J. Immunol.Home page
V. Zacharioudaki, A. Androulidaki, A. Arranz, G. Vrentzos, A. N. Margioris, and C. Tsatsanis
Adiponectin Promotes Endotoxin Tolerance in Macrophages by Inducing IRAK-M Expression
J. Immunol., May 15, 2009; 182(10): 6444 - 6451.
[Abstract] [Full Text] [PDF]